Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-31

Clinical Trial Update: Comparison of Neuromuscular Blockade's Monitoring and Clinical Assessment During Cisatracurium Paralysis in Critically Ill Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing neuromuscular blockade monitoring approaches with clinical assessment during cisatracurium-induced paralysis in critically il…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cisatracurium (Cisatracurium besylate)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Critical Illness | Phase 3 | Status: COMPLETED